ANI Pharmaceuticals, Inc. · Drug Manufacturers - Specialty & Generic

ANIPANI Pharmaceuticals, Inc.

Reports 2026-11-11 · WedReaction day 11-12upcoming

Before the print · expectations16 days to the print

Street consensus

$2.22EPS
$286MRevenue

No past prints on file yet.

What the record doesn't tell you

Which way does ANIP go on 11‑11?

  • Model lean for 11-11, and the evidence behind it
  • Move band, P10 – P90
  • Last 8 prints, quarter by quarter
  • Peers that already reported, and how they traded
Start 30-day free trialFull access · no card requiredHave an account? Sign inThe lean freezes the night before the print.

The print · 8-K and callupcoming · 2026-11-11

Revenue—
est. $286M
EPS—
est. $2.22
Guidance—read from the 8-K once filed

Lean, stance and evidence on this page are model outputs, not investment advice. Trade at your own risk. Disclaimer →

ANI Pharmaceuticals earnings preview: what the record says

ANI Pharmaceuticals (ANIP) is scheduled to report earnings on Nov 11, 2026. The consensus estimate calls for EPS of $2.22 on revenue of $286M.

Figures come from NextPick's earnings-reaction ledger and the options market. Not investment advice.

ANIP earnings: key questions

When is ANIP's next earnings date?

ANI Pharmaceuticals is scheduled to report on Nov 11, 2026.

What are ANIP's earnings expectations?

Analysts expect EPS of $2.22 on revenue of $286M for the quarter.